{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T01:37:31Z","timestamp":1790127451190,"version":"4.0.1"},"reference-count":161,"publisher":"MDPI AG","issue":"22","license":[{"start":{"date-parts":[[2019,11,14]],"date-time":"2019-11-14T00:00:00Z","timestamp":1573689600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Epidermolysis bullosa (EB) is a heterogeneous group of inherited skin disorders determined by mutations in genes encoding for structural components of the cutaneous basement membrane zone. Disease hallmarks are skin fragility and unremitting blistering. The most disabling EB (sub)types show defective wound healing, fibrosis and inflammation at lesional skin. These features expose patients to serious disease complications, including the development of cutaneous squamous cell carcinomas (SCCs). Almost all subjects affected with the severe recessive dystrophic EB (RDEB) subtype suffer from early and extremely aggressive SCCs (RDEB-SCC), which represent the first cause of death in these patients. The genetic determinants of RDEB-SCC do not exhaustively explain its unique behavior as compared to low-risk, ultraviolet-induced SCCs in the general population. On the other hand, a growing body of evidence points to the key role of tumor microenvironment in initiation, progression and spreading of RDEB-SCC, as well as of other, less-investigated, EB-related SCCs (EB-SCCs). Here, we discuss the recent advances in understanding the complex series of molecular events (i.e., fibrotic, inflammatory, and immune processes) contributing to SCC development in EB patients, cross-compare tumor features in the different EB subtypes and report the most promising therapeutic approaches to counteract or delay EB-SCCs.<\/jats:p>","DOI":"10.3390\/ijms20225707","type":"journal-article","created":{"date-parts":[[2019,11,14]],"date-time":"2019-11-14T10:56:34Z","timestamp":1573728994000},"page":"5707","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":108,"title":["Epidermolysis Bullosa-Associated Squamous Cell Carcinoma: From Pathogenesis to Therapeutic Perspectives"],"prefix":"10.3390","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1502-5852","authenticated-orcid":false,"given":"Angelo Giuseppe","family":"Condorelli","sequence":"first","affiliation":[{"name":"Genetics and Rare Diseases Research Division, Bambino Ges\u00f9 Children\u2019s Hospital, IRCCS, viale di San Paolo 15, 00146 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4329-3312","authenticated-orcid":false,"given":"Elena","family":"Dellambra","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular and Cell Biology, IDI-IRCCS, via Monti di Creta 104, 00167 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Logli","sequence":"additional","affiliation":[{"name":"Genetics and Rare Diseases Research Division, Bambino Ges\u00f9 Children\u2019s Hospital, IRCCS, viale di San Paolo 15, 00146 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanna","family":"Zambruno","sequence":"additional","affiliation":[{"name":"Genetics and Rare Diseases Research Division, Bambino Ges\u00f9 Children\u2019s Hospital, IRCCS, viale di San Paolo 15, 00146 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3501-6742","authenticated-orcid":false,"given":"Daniele","family":"Castiglia","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular and Cell Biology, IDI-IRCCS, via Monti di Creta 104, 00167 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2019,11,14]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/j.jaad.2014.01.903","article-title":"Inherited epidermolysis bullosa: Updated recommendations on diagnosis and classification","volume":"70","author":"Fine","year":"2014","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Has, C., Liu, L., Bolling, M.C., Charlesworth, A.V., El Hachem, M., Esc\u00e1mez, M.J., Fuentes, I., B\u00fcchel, S., Hiremagalore, R., and Pohla-Gubo, G. (2019). Clinical practice guidelines for laboratory diagnosis of epidermolysis bullosa. Br. J. Dermatol., 15.","DOI":"10.1111\/bjd.18829"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.jaad.2016.08.019","article-title":"Incidence ratio of basal cell carcinoma to squamous cell carcinoma equalizes with age","volume":"76","author":"Chahal","year":"2017","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/bjd.17873","article-title":"Epidemiology of basal and cutaneous squamous cell carcinoma in the U.K. 2013-15: A cohort study","volume":"181","author":"Venables","year":"2019","journal-title":"Br. J. Dermatol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jaad.2017.08.059","article-title":"Cutaneous squamous cell carcinoma: Incidence, risk factors, diagnosis, and staging","volume":"78","author":"Que","year":"2018","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/bjd.15324","article-title":"Cutaneous squamous cell carcinoma: An epidemiological review","volume":"177","author":"Green","year":"2017","journal-title":"Br. J. Dermatol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"3667","DOI":"10.1038\/s41467-018-06027-1","article-title":"The genomic landscape of cutaneous SCC reveals drivers and a novel azathioprine associated mutational signature","volume":"9","author":"Inman","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1111\/jdv.13180","article-title":"Evidence and consensus-based (S3) guidelines for the treatment of actinic keratosis \u2013 International League of Dermatological Societies in cooperation with the European Dermatology Forum\u2013short version","volume":"29","author":"Werner","year":"2015","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1111\/bjd.12420","article-title":"The natural history of actinic keratosis: A systematic review","volume":"169","author":"Werner","year":"2013","journal-title":"Br. J. Dermatol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"12601","DOI":"10.1038\/ncomms12601","article-title":"Cross-species identification of genomic drivers of squamous cell carcinoma development across preneoplastic intermediates","volume":"7","author":"Chitsazzadeh","year":"2016","journal-title":"Nat. Commun."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.jid.2017.07.844","article-title":"Subclonal evolution of cancer-related gene mutations in p53 immunopositive patches in human skin","volume":"138","author":"Albibas","year":"2018","journal-title":"J. Investig. Dermatol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1002\/hed.24580","article-title":"Review of high-risk features of cutaneous squamous cell carcinoma and discrepancies between the American Joint Committee on Cancer and NCCN clinical practice guidelines in oncology","volume":"39","author":"Skulsky","year":"2017","journal-title":"Head Neck"},{"key":"ref_13","first-page":"197","article-title":"Marjolin\u2019s ulcer in chronic wounds - review of available literature","volume":"21","year":"2017","journal-title":"Contemp. Oncol."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Foster, D.S., Jones, R.E., Ransom, R.C., Longaker, M.T., and Norton, J.A. (2018). The evolving relationship of wound healing and tumor stroma. JCI Insight, 3.","DOI":"10.1172\/jci.insight.99911"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"e14","DOI":"10.1097\/BCR.0000000000000432","article-title":"Transcriptional analysis reveals evidence of chronically impeded ECM turnover and epithelium-to-mesenchyme transition in scar tissue giving rise to Marjolin\u2019s ulcer","volume":"38","author":"Sinha","year":"2017","journal-title":"J. Burn Care Res."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1056\/NEJM198612253152606","article-title":"Tumors: Wounds that do not heal. Similarities between tumor stroma generation and wound healing","volume":"315","author":"Dvorak","year":"1986","journal-title":"N. Engl. J. Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1016\/j.ajpath.2017.03.003","article-title":"Pathomechanisms of altered wound healing in recessive dystrophic epidermolysis bullosa","volume":"187","author":"Cianfarani","year":"2017","journal-title":"Am. J. Pathol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s13023-016-0489-9","article-title":"Inherited epidermolysis bullosa and squamous cell carcinoma: A systematic review of 117 cases","volume":"11","author":"Chiaverini","year":"2016","journal-title":"Orphanet. J. Rare Dis."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1001\/jamadermatol.2016.2473","article-title":"Epidemiology of inherited epidermolysis bullosa based on incidence and prevalence estimates from the national epidermolysis bullosa registry","volume":"152","author":"Fine","year":"2016","journal-title":"JAMA Dermatol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.ad.2013.03.006","article-title":"Prevalence of dystrophic epidermolysis bullosa in Spain: A population-based study using the 3-source capture-recapture method. Evidence of a need for improvement in care","volume":"104","author":"Aranegui","year":"2013","journal-title":"Actas Dermosifiliogr."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1111\/j.1365-2133.1997.tb02141.x","article-title":"The prevalence of epidermolysis bullosa in Scotland","volume":"136","author":"Horn","year":"1997","journal-title":"Br. J. Dermatol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.jaad.2009.03.052","article-title":"Extracutaneous manifestations and complications of inherited epidermolysis bullosa: Part I. Epithelial associated tissues","volume":"61","author":"Fine","year":"2009","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.jaad.2009.03.053","article-title":"Extracutaneous manifestations and complications of inherited epidermolysis bullosa: Part II. Other organs","volume":"61","author":"Fine","year":"2009","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Has, C., Nystr\u00f6m, A., Saeidian, A.H., Bruckner-Tuderman, L., and Uitto, J. (2018). Epidermolysis bullosa: Molecular pathology of connective tissue components in the cutaneous basement membrane zone. Matrix Biol., 71\u201372.","DOI":"10.1016\/j.matbio.2018.04.001"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.jaad.2008.09.035","article-title":"Epidermolysis bullosa and the risk of life-threatening cancers: The National EB Registry experience, 1986\u20132006","volume":"60","author":"Fine","year":"2009","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/bjd.14104","article-title":"Management of cutaneous squamous cell carcinoma in patients with epidermolysis bullosa: Best clinical practice guidelines","volume":"174","author":"Mellerio","year":"2016","journal-title":"Br. J. Dermatol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1126\/science.aaa6806","article-title":"Tumor evolution. High burden and pervasive positive selection of somatic mutations in normal human skin","volume":"348","author":"Martincorena","year":"2015","journal-title":"Science"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"14025","DOI":"10.1073\/pnas.93.24.14025","article-title":"Frequent clones of p53-mutated keratinocytes in normal human skin","volume":"93","author":"Jonason","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: The next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/j.jid.2017.12.026","article-title":"Genetic profiles of squamous cell carcinomas associated with recessive dystrophic epidermolysis bullosa unveil NOTCH and TP53 mutations and an increased MYC expression","volume":"138","author":"Ferrer","year":"2018","journal-title":"J. Investig. Dermatol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"eaas9668","DOI":"10.1126\/scitranslmed.aas9668","article-title":"APOBEC mutation drives early-onset squamous cell carcinomas in recessive dystrophic epidermolysis bullosa","volume":"10","author":"Cho","year":"2018","journal-title":"Sci. Transl. Med."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"6582","DOI":"10.1158\/1078-0432.CCR-14-1768","article-title":"Mutational landscape of aggressive cutaneous squamous cell carcinoma","volume":"20","author":"Pickering","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1158\/1078-0432.CCR-14-1773","article-title":"Genomic analysis of metastatic cutaneous squamous cell carcinoma","volume":"21","author":"Li","year":"2015","journal-title":"Clin. Cancer. Res."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1038\/ng1099","article-title":"Notch1 functions as a tumor suppressor in mouse skin","volume":"33","author":"Nicolas","year":"2003","journal-title":"Nat. Genet."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Dainichi, T., Nakano, Y., Wakae, K., Otsuka, M., Muramatsu, M., and Kabashima, K. (2019). APOBEC3 regulates keratinocyte differentiation and expression of Notch3. Exp. Dermatol., 10.","DOI":"10.1111\/exd.14019"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1002\/pro.3670","article-title":"APOBEC3s: DNA-editing human cytidine deaminases","volume":"28","author":"Silvas","year":"2019","journal-title":"Protein Sci."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1016\/j.cell.2019.02.012","article-title":"Characterizing mutational signatures in human cancer cell lines reveals episodic APOBEC mutagenesis","volume":"176","author":"Petljak","year":"2019","journal-title":"Cell"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/nature07039","article-title":"Wound repair and regeneration","volume":"453","author":"Gurtner","year":"2008","journal-title":"Nature"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.matbio.2018.01.019","article-title":"The big five in fibrosis: Macrophages, myofibroblasts, matrix, mechanics, and miscommunication","volume":"68\u201369","author":"Pakshir","year":"2018","journal-title":"Matrix Biol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.yexcr.2019.03.027","article-title":"Mechanical regulation of myofibroblast phenoconversion and collagen contraction","volume":"379","author":"Hinz","year":"2019","journal-title":"Exp. Cell Res."},{"key":"ref_41","first-page":"547","article-title":"Injury- and inflammation-driven skin fibrosis: The paradigm of epidermolysis bullosa","volume":"68","year":"2018","journal-title":"Matrix Biol."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Condorelli, A.G., Logli, E., Cianfarani, F., Teson, M., Diociaiuti, A., El Hachem, M., Zambruno, G., Castiglia, D., and Odorisio, T. (2019). miR-145-5p regulates fibrotic features of recessive dystrophic epidermolysis bullosa skin fibroblasts. Br. J. Dermatol., 28.","DOI":"10.1111\/bjd.17840"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"3907","DOI":"10.1093\/hmg\/ddu102","article-title":"Monozygotic twins discordant for recessive dystrophic epidermolysis bullosa phenotype highlight the role of TGF-\u03b2 signalling in modifying disease severity","volume":"23","author":"Odorisio","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1172\/JCI34292","article-title":"A hypomorphic mouse model of dystrophic epidermolysis bullosa reveals mechanisms of disease and response to fibroblast therapy","volume":"118","author":"Fritsch","year":"2008","journal-title":"J. Clin. Investig."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.15252\/emmm.201505061","article-title":"Losartan ameliorates dystrophic epidermolysis bullosa and uncovers new disease mechanisms","volume":"7","author":"Thriene","year":"2015","journal-title":"EMBO Mol. Med."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.matbio.2018.12.001","article-title":"Decorin counteracts disease progression in mice with recessive dystrophic epidermolysis bullosa","volume":"81","author":"Cianfarani","year":"2019","journal-title":"Matrix Biol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1016\/j.jid.2019.01.011","article-title":"Thrombospondin-1 is a major activator of TGF-\u03b2 signaling in recessive dystrophic epidermolysis bullosa fibroblasts","volume":"139","author":"Atanasova","year":"2019","journal-title":"J. Investig. Dermatol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"5480","DOI":"10.18632\/oncotarget.23869","article-title":"Decorin is a pivotal effector in the extracellular matrix and tumour microenvironment","volume":"9","author":"Zhang","year":"2018","journal-title":"Oncotarget"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"3522","DOI":"10.1158\/0008-5472.CAN-11-2996","article-title":"Fibroblast-derived dermal matrix drives development of aggressive cutaneous squamous cell carcinoma in patients with recessive dystrophic epidermolysis bullosa","volume":"72","author":"Ng","year":"2012","journal-title":"Cancer Res."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.matbio.2017.01.002","article-title":"Stromal microenvironment in type VII collagen-deficient skin: The ground for squamous cell carcinoma development","volume":"63","author":"Guerra","year":"2017","journal-title":"Matrix Biol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"60","DOI":"10.3389\/fcell.2019.00060","article-title":"Cancer-associated fibroblasts build and secure the tumor microenvironment","volume":"7","author":"Liu","year":"2019","journal-title":"Front. Cell Dev. Biol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/msb.2013.17","article-title":"Global remodelling of cellular microenvironment due to loss of collagen VII","volume":"9","author":"Mack","year":"2013","journal-title":"Mol. Syst. Biol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/bjd.17698","article-title":"Fibroblast activation and abnormal extracellular matrix remodelling as common hallmarks in three cancer-prone genodermatoses","volume":"181","author":"Conti","year":"2019","journal-title":"Br. J. Dermatol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.matbio.2017.11.004","article-title":"Identification of tissue damage, extracellular matrix remodeling and bacterial challenge as common mechanisms associated with high-risk cutaneous squamous cell carcinomas","volume":"66","author":"Fahrner","year":"2018","journal-title":"Matrix Biol."},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Kiraly, O., Gong, G., Olipitz, W., Muthupalani, S., and Engelward, B.P. (2015). Inflammation-induced cell proliferation potentiates DNA damage-induced mutations in vivo. PLoS Genet., 11.","DOI":"10.1371\/journal.pgen.1004901"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1535293","DOI":"10.1080\/2162402X.2018.1535293","article-title":"Tumor-associated B cells and humoral immune response in head and neck squamous cell carcinoma","volume":"8","author":"Lechner","year":"2019","journal-title":"Oncoimmunology"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1074\/mcp.RA117.000437","article-title":"Combinatorial omics analysis reveals perturbed lysosomal homeostasis in collagen VII-deficient keratinocytes","volume":"17","author":"Thriene","year":"2018","journal-title":"Mol. Cell. Proteomics."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1242\/jcs.042895","article-title":"Increased invasive behaviour in cutaneous squamous cell carcinoma with loss of basement-membrane type VII collagen","volume":"122","author":"Martins","year":"2009","journal-title":"J. Cell Sci."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"djv293","DOI":"10.1093\/jnci\/djv293","article-title":"Suppression of TGF\u03b2 and angiogenesis by type VII collagen in cutaneous SCC","volume":"108","author":"Martins","year":"2015","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Hao, Y., Baker, D., and Ten Dijke, P. (2019). TGF-\u03b2-mediated epithelial-mesenchymal transition and cancer metastasis. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20112767"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1158\/0008-5472.CAN-15-1348","article-title":"Injury-driven stiffening of the dermis expedites skin carcinoma progression","volume":"76","author":"Mittapalli","year":"2016","journal-title":"Cancer Res."},{"key":"ref_62","first-page":"740","article-title":"Type VII collagen regulates expression of OATP1B3, promotes front-to-rear polarity and increases structural organisation in 3D spheroid cultures of RDEB tumour keratinocytes","volume":"127","author":"Dayal","year":"2014","journal-title":"J. Cell Sci."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/j.jid.2017.11.022","article-title":"Extracellular vesicles as biomarkers for the detection of a tumor marker gene in epidermolysis bullosa-associated squamous cell carcinoma","volume":"138","author":"Sun","year":"2018","journal-title":"J. Investig. Dermatol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1038\/jid.2014.185","article-title":"Loss of collagen VII is associated with reduced transglutaminase 2 abundance and activity","volume":"134","author":"Mack","year":"2014","journal-title":"J. Investig. Dermatol."},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Yun, C.W., and Lee, S.H. (2018). The roles of autophagy in cancer. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19113466"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"93757","DOI":"10.18632\/oncotarget.20771","article-title":"Autophagy protein LC3 regulates the fibrosis of hypertrophic scar by controlling Bcl-xL in dermal fibroblasts","volume":"8","author":"Shi","year":"2017","journal-title":"Oncotarget"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1016\/j.jid.2016.05.115","article-title":"miR-29 Regulates Type VII collagen in recessive dystrophic epidermolysis bullosa","volume":"136","author":"Muldoon","year":"2016","journal-title":"J. Investig. Dermatol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s40659-017-0127-6","article-title":"MicroRNA-98 inhibits the cell proliferation of human hypertrophic scar fibroblasts via targeting Col1A1","volume":"50","author":"Bi","year":"2017","journal-title":"Biol. Res."},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Garc\u00eda-Sancha, N., Corchado-Cobos, R., P\u00e9rez-Losada, J., and Ca\u00f1ueto, J. (2019). MicroRNA dysregulation in cutaneous squamous cell carcinoma. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20092181"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1002\/stem.2907","article-title":"Cord blood-derived stem cells suppress fibrosis and may prevent malignant progression in recessive dystrophic epidermolysis bullosa","volume":"36","author":"Liao","year":"2018","journal-title":"Stem Cells"},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Esposito, S., Guez, S., Orenti, A., Tadini, G., Scuvera, G., Corti, L., Scala, A., Biganzoli, E., Berti, E., and Principi, N. (2016). Autoimmunity and cytokine imbalance in inherited epidermolysis bullosa. Int. J. Mol. Sci., 17.","DOI":"10.3390\/ijms17101625"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1093\/rheumatology\/kex347","article-title":"Role of STAT3 in skin fibrosis and transforming growth factor beta signalling","volume":"57","author":"Pedroza","year":"2018","journal-title":"Rheumatology"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"4957","DOI":"10.1158\/0008-5472.CAN-17-2268","article-title":"IL-6 mediates cross-talk between tumor cells and activated fibroblasts in the tumor microenvironment","volume":"78","author":"Karakasheva","year":"2018","journal-title":"Cancer Res."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.wjorl.2016.05.002","article-title":"Interleukin-6 role in head and neck squamous cell carcinoma progression","volume":"2","author":"Choudhary","year":"2016","journal-title":"World J. Otorhinolaryngol. Head Neck Surg."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/onc.2017.387","article-title":"IL6 derived from cancer-associated fibroblasts promotes chemoresistance via CXCR7 in esophageal squamous cell carcinoma","volume":"37","author":"Qiao","year":"2018","journal-title":"Oncogene"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"20741","DOI":"10.18632\/oncotarget.15119","article-title":"IL-6 secreted by cancer-associated fibroblasts promotes epithelial-mesenchymal transition and metastasis of gastric cancer via JAK2\/STAT3 signaling pathway","volume":"8","author":"Wu","year":"2017","journal-title":"Oncotarget"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/nrclinonc.2018.8","article-title":"Targeting the IL-6\/JAK\/STAT3 signalling axis in cancer","volume":"15","author":"Johnson","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"4046","DOI":"10.1158\/1078-0432.CCR-13-0495","article-title":"HMGB1 in cancer: Good, bad, or both?","volume":"19","author":"Kang","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.toxrep.2019.03.002","article-title":"HMGB1 protein as a novel target for cancer","volume":"6","author":"Tripathi","year":"2019","journal-title":"Toxicol. Rep."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3892\/ol.2015.3843","article-title":"High mobility group box 1 regulates tumor metastasis in cutaneous squamous cell carcinoma via the PI3K\/AKT and MAPK signaling pathways","volume":"11","author":"Sun","year":"2016","journal-title":"Oncol. Lett."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/exd.12152","article-title":"Serum levels of high mobility group box 1 correlate with disease severity in recessive dystrophic epidermolysis bullosa","volume":"22","author":"Petrof","year":"2013","journal-title":"Exp. Dermatol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"6609","DOI":"10.1073\/pnas.1016753108","article-title":"PDGFRalpha-positive cells in bone marrow are mobilized by high mobility group box 1 (HMGB1) to regenerate injured epithelia","volume":"108","author":"Tamai","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"5932","DOI":"10.1038\/ncomms6932","article-title":"Innate sensing of microbial products promotes wound-induced skin cancer","volume":"6","author":"Hoste","year":"2015","journal-title":"Nat. Commun."},{"key":"ref_84","first-page":"E705","article-title":"Impaired lymphoid extracellular matrix impedes antibacterial immunity in epidermolysis bullosa","volume":"115","author":"Bornert","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1038\/jid.2012.347","article-title":"High anti-staphylococcal antibody titers in patients with epidermolysis bullosa relate to long-term colonization with alternating types of Staphylococcus aureus","volume":"133","author":"Duipmans","year":"2013","journal-title":"J. Investig. Dermatol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/0305-4179(95)00047-F","article-title":"Microbial colonization of large wounds","volume":"21","author":"Vindenes","year":"1995","journal-title":"Burns"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"2853","DOI":"10.1038\/jid.2010.243","article-title":"No evidence that human papillomavirus is responsible for the aggressive nature of recessive dystrophic epidermolysis bullosa-associated squamous cell carcinoma","volume":"130","author":"Purdie","year":"2010","journal-title":"J. Investig. Dermatol."},{"key":"ref_88","doi-asserted-by":"crossref","unstructured":"Bottomley, M.J., Thomson, J., Harwood, C., and Leigh, I. (2019). The role of the immune system in cutaneous squamous cell carcinoma. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20082009"},{"key":"ref_89","doi-asserted-by":"crossref","unstructured":"Riihil\u00e4, P., Viiklepp, K., Nissinen, L., Farshchian, M., Kallajoki, M., Kivisaari, A., Meri, S., Peltonen, J., Peltonen, S., and K\u00e4h\u00e4ri, V.M. (2019). Tumour-cell-derived complement components C1r and C1s promote growth of cutaneous squamous cell carcinoma. Br. J. Dermatol., 3.","DOI":"10.1111\/bjd.18095"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/bjd.12272","article-title":"Use of cetuximab as an adjuvant agent to radiotherapy and surgery in recessive dystrophic epidermolysis bullosa with squamous cell carcinoma","volume":"169","author":"Kim","year":"2013","journal-title":"Br. J. Dermatol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1159\/000218714","article-title":"Cetuximab therapy of metastasizing cutaneous squamous cell carcinoma in a patient with severe recessive dystrophic epidermolysis bullosa","volume":"219","author":"Arnold","year":"2009","journal-title":"Dermatology"},{"key":"ref_92","first-page":"448","article-title":"Wound healing deficits in severe generalized recessive dystrophic epidermolysis bullosa along anticancer treatment with cetuximab","volume":"17","author":"Medek","year":"2019","journal-title":"J. Dtsch. Dermatol. Ges."},{"key":"ref_93","doi-asserted-by":"crossref","unstructured":"Reimer, A., Lu, S., He, Y., Bruckner-Tuderman, L., Technau-Hafsi, K., Meiss, F., Has, C., and von Bubnoff, D. (2019). Combined anti-inflammatory and low-dose antiproliferative therapy for squamous cell carcinomas in recessive dystrophic epidermolysis bullosa. J. Eur. Acad. Dermatol. Venereol., 2.","DOI":"10.1111\/jdv.15835"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"70","DOI":"10.2340\/00015555-2781","article-title":"Epidemiology and outcome of squamous cell carcinoma in epidermolysis bullosa in Australia and New Zealand","volume":"98","author":"Kim","year":"2018","journal-title":"Acta Derm. Venereol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"S223","DOI":"10.1016\/j.jid.2017.07.176","article-title":"179 Systemic administration of HMGB1 peptide drastically improves survival of the RDEB model mice by mobilizing multipotent stem\/progenitor cells from bone marrow","volume":"137","author":"Tamai","year":"2017","journal-title":"J. Investig. Dermatol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/s10545-017-0055-1","article-title":"High-content drug screening for rare diseases","volume":"40","author":"Bellomo","year":"2017","journal-title":"J. Inherit. Metab. Dis."},{"key":"ref_97","doi-asserted-by":"crossref","unstructured":"Osborn, M.J., Newby, G.A., McElroy, A.N., Knipping, F., Nielsen, S.C., Riddle, M.J., Xia, L., Chen, W., Eide, C.R., and Webber, B.R. (2019). Base editor correction of COL7A1 in recessive dystrophic epidermolysis bullosa patient-derived fibroblasts and iPSCs. J. Investig. Dermatol., 19.","DOI":"10.1016\/j.jid.2019.07.701"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"126243","DOI":"10.1172\/jci.insight.126243","article-title":"Safety and early efficacy outcomes for lentiviral fibroblast gene therapy in recessive dystrophic epidermolysis bullosa","volume":"4","author":"Lwin","year":"2019","journal-title":"JCI Insight"},{"key":"ref_99","doi-asserted-by":"crossref","unstructured":"Gaucher, S., Lwin, S.M., Titeux, M., Abdul-Wahab, A., Pironon, N., Izmiryan, A., Miskinyte, S., Ganier, C., Duchatelet, S., and Mellerio, J.E. (2019). EBGene trial: Patient pre-selection outcomes for the European GENEGRAFT ex vivo phase I\/II gene therapy trial for recessive dystrophic epidermolysis bullosa. Br. J. Dermatol., 26.","DOI":"10.1111\/bjd.18559"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.omtn.2018.01.009","article-title":"Deletion of a pathogenic mutation-containing exon of COL7A1 allows clonal gene editing correction of RDEB patient epidermal stem cells","volume":"11","author":"Chamorro","year":"2018","journal-title":"Mol. Ther. Nucleic Acids."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.ymthe.2019.03.007","article-title":"Clinically relevant correction of recessive dystrophic epidermolysis bullosa by dual sgRNA CRISPR\/Cas9-mediated gene editing","volume":"27","author":"Bonafont","year":"2019","journal-title":"Mol Ther."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"380","DOI":"10.15252\/emmm.201404353","article-title":"A single epidermal stem cell strategy for safe ex vivo gene therapy","volume":"7","author":"Rochat","year":"2015","journal-title":"EMBO Mol. Med."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1001\/jama.2016.15588","article-title":"Safety and wound outcomes following genetically corrected autologous epidermal grafts in patients with recessive dystrophic epidermolysis bullosa","volume":"316","author":"Siprashvili","year":"2016","journal-title":"JAMA"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"130554","DOI":"10.1172\/jci.insight.130554","article-title":"Phase 1\/2a clinical trial of gene-corrected autologous cell therapy for recessive dystrophic epidermolysis bullosa","volume":"4","author":"Eichstadt","year":"2019","journal-title":"JCI Insight"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/nature24487","article-title":"Regeneration of the entire human epidermis using transgenic stem cells","volume":"551","author":"Hirsch","year":"2017","journal-title":"Nature"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1038\/mt.2009.144","article-title":"Mechanisms of fibroblast cell therapy for dystrophic epidermolysis bullosa: High stability of collagen VII favors long-term skin integrity","volume":"17","author":"Kern","year":"2009","journal-title":"Mol. Ther."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1038\/mt.2015.58","article-title":"High local concentrations of intradermal MSCs restore skin integrity and facilitate wound healing in dystrophic epidermolysis bullosa","volume":"23","author":"Mezger","year":"2015","journal-title":"Mol. Ther."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1182\/blood-2008-06-161299","article-title":"Amelioration of epidermolysis bullosa by transfer of wild-type bone marrow cells","volume":"113","author":"Tolar","year":"2009","journal-title":"Blood"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.4049\/jimmunol.1400914","article-title":"Transplanted bone marrow-derived circulating PDGFR\u03b1+ cells restore type VII collagen in recessive dystrophic epidermolysis bullosa mouse skin graft","volume":"194","author":"Iinuma","year":"2015","journal-title":"J. Immunol."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"303","DOI":"10.3727\/096368913X663569","article-title":"Human cord blood-derived unrestricted somatic stem cells promote wound healing and have therapeutic potential for patients with recessive dystrophic epidermolysis bullosa","volume":"23","author":"Liao","year":"2014","journal-title":"Cell Transplant."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1002\/stem.1966","article-title":"Rescue of the mucocutaneous manifestations by human cord blood derived nonhematopoietic stem cells in a mouse model of recessive dystrophic epidermolysis bullosa","volume":"33","author":"Liao","year":"2015","journal-title":"Stem Cells."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/wrr.12398","article-title":"Transforming growth factor beta (TGF-\u03b2) isoforms in wound healing and fibrosis","volume":"24","author":"Lichtman","year":"2016","journal-title":"Wound Repair Regen."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1038\/jid.2008.78","article-title":"Potential of fibroblast cell therapy for recessive dystrophic epidermolysis bullosa","volume":"128","author":"Wong","year":"2008","journal-title":"J. Investig. Dermatol."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1056\/NEJMoa0910501","article-title":"Bone marrow transplantation for recessive dystrophic epidermolysis bullosa","volume":"363","author":"Wagner","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1111\/bjd.12599","article-title":"Fibroblast cell therapy enhances initial healing in recessive dystrophic epidermolysis bullosa wounds: Results of a randomized, vehicle-controlled trial","volume":"169","author":"Petrof","year":"2013","journal-title":"Br. J. Dermatol."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1038\/jid.2015.158","article-title":"Potential of systemic allogenic mesenchymal stromal cell therapy for children with recessive dystrophic epidermolysis bullosa","volume":"135","author":"Petrof","year":"2015","journal-title":"J. Investig. Dermatol."},{"key":"ref_117","doi-asserted-by":"crossref","unstructured":"Ebens, C.L., McGrath, J.A., Tamai, K., Hovnanian, A., Wagner, J.E., Riddle, M.J., Keene, D.R., DeFor, T.E., Tryon, R., and Chen, M. (2019). Bone marrow transplant with post-transplant cyclophosphamide for recessive dystrophic epidermolysis bullosa expands the related donor pool and permits tolerance of nonhaematopoietic cellular grafts. Br. J. Dermatol., 6.","DOI":"10.1111\/bjd.17858"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/mt.2008.234","article-title":"Injection of recombinant human type VII collagen corrects the disease phenotype in a murine model of dystrophic epidermolysis bullosa","volume":"17","author":"Remington","year":"2009","journal-title":"Mol. Ther."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/mt.2008.262","article-title":"Can type VII collagen injections cure dystrophic epidermolysis bullosa?","volume":"17","year":"2009","journal-title":"Mol. Ther."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"e379","DOI":"10.1038\/mtna.2016.87","article-title":"Antisense oligonucleotide-mediated exon skipping as a systemic therapeutic approach for recessive dystrophic epidermolysis bullosa","volume":"5","author":"Bremer","year":"2016","journal-title":"Mol. Ther. Nucleic Acids."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1016\/j.jid.2016.07.029","article-title":"Targeted exon skipping restores Type VII collagen expression and anchoring fibril formation in an in vivo RDEB model","volume":"136","author":"Turczynski","year":"2016","journal-title":"J. Investig. Dermatol."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"3028","DOI":"10.1172\/JCI92707","article-title":"Gentamicin induces functional type VII collagen in recessive dystrophic epidermolysis bullosa patients","volume":"127","author":"Woodley","year":"2017","journal-title":"J. Clin. Investig."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1016\/j.jid.2017.05.011","article-title":"Amlexanox enhances premature termination codon read-through in COL7A1 and expression of full length type VII collagen: Potential therapy for recessive dystrophic epidermolysis bullosa","volume":"137","author":"Atanasova","year":"2017","journal-title":"J. Investig. Dermatol."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"4666","DOI":"10.1038\/onc.2011.180","article-title":"Integrative mRNA profiling comparing cultured primary cells with clinical samples reveals PLK1 and C20orf20 as therapeutic targets in cutaneous squamous cell carcinoma","volume":"30","author":"Watt","year":"2011","journal-title":"Oncogene"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.tranon.2016.10.003","article-title":"PLK1, a potential target for cancer therapy","volume":"10","author":"Liu","year":"2017","journal-title":"Transl. Oncol."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"3384","DOI":"10.1158\/1078-0432.CCR-18-2661","article-title":"Identification of rigosertib for the treatment of recessive dystrophic epidermolysis bullosa-associated squamous cell carcinoma","volume":"25","author":"Atanasova","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1111\/j.1365-2133.2011.10553.x","article-title":"Herlitz junctional epidermolysis bullosa: Diagnostic features, mutational profile, incidence and population carrier frequency in the Netherlands","volume":"165","author":"Yuen","year":"2011","journal-title":"Br. J. Dermatol."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1111\/j.1365-2133.2012.10997.x","article-title":"Long-term follow-up of patients with Herlitz-type junctional epidermolysis bullosa","volume":"167","author":"Yuen","year":"2012","journal-title":"Br. J. Dermatol."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.jaad.2010.07.006","article-title":"Risk of squamous cell carcinoma in junctional epidermolysis bullosa, non-Herlitz type: Report of 7 cases and a review of the literature","volume":"65","author":"Yuen","year":"2011","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"122","DOI":"10.4161\/cam.23132","article-title":"Laminin 332 processing impacts cellular behaviour","volume":"7","author":"Rousselle","year":"2013","journal-title":"Cell. Adh. Migr."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1159\/000357032","article-title":"Processing of laminin \u03b1 chains generates peptides involved in wound healing and host defense","volume":"6","author":"Kempf","year":"2014","journal-title":"J. Innate Immun."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1242\/jcs.01003","article-title":"Laminin 5 deposition regulates keratinocyte polarization and persistent migration","volume":"117","author":"Frank","year":"2004","journal-title":"J. Cell Sci."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"2885","DOI":"10.1158\/0008-5472.CAN-07-6160","article-title":"Targeting a tumor-specific laminin domain critical for human carcinogenesis","volume":"68","author":"Tran","year":"2008","journal-title":"Cancer Res."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/nature01283","article-title":"NF-kappaB blockade and oncogenic Ras trigger invasive human epidermal neoplasia","volume":"421","author":"Dajee","year":"2003","journal-title":"Nature"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"4264","DOI":"10.1158\/0008-5472.CAN-06-4141","article-title":"A laminin-collagen complex drives human epidermal carcinogenesis through phosphoinositol-3-kinase activation","volume":"67","author":"Waterman","year":"2007","journal-title":"Cancer Res."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1038\/nrc2089","article-title":"Tumor microenvironment: Laminin 332 in squamous-cell carcinoma","volume":"7","author":"Marinkovich","year":"2007","journal-title":"Nat. Rev. Cancer"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1081\/RRS-200047870","article-title":"Laminin alpha3 LG4 module induces keratinocyte migration: Involvement of matrix metalloproteinase-9","volume":"25","author":"Momota","year":"2005","journal-title":"J. Recept. Signal Transduct. Res."},{"key":"ref_138","doi-asserted-by":"crossref","unstructured":"Cavaco, A.C.M., Rezaei, M., Caliandro, M.F., Lima, A.M., Stehling, M., Dhayat, S.A., Haier, J., Brakebusch, C., and Eble, J.A. (2018). The interaction between Laminin-332 and \u03b13\u03b21 integrin determines differentiation and maintenance of CAFs, and supports invasion of pancreatic duct adenocarcinoma cells. Cancers, 11.","DOI":"10.3390\/cancers11010014"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.matbio.2009.07.008","article-title":"Defining the role of laminin-332 in carcinoma","volume":"28","author":"Guess","year":"2009","journal-title":"Matrix Biol."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1097\/PAI.0000000000000115","article-title":"Overexpression of \u03b23 chains of laminin-332 is associated with clinicopathologic features and decreased survival in patients with pancreatic adenocarcinoma","volume":"23","author":"Chen","year":"2015","journal-title":"Appl. Immunohistochem. Mol. Morphol."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.humpath.2018.08.003","article-title":"Laminin 332 expression and prognosis in breast cancer","volume":"82","author":"Carpenter","year":"2018","journal-title":"Hum. Pathol."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ymthe.2017.09.022","article-title":"Targeting of cell surface proteolysis of collagen XVII impedes squamous cell carcinoma progression","volume":"26","author":"Galiger","year":"2018","journal-title":"Mol. Ther."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1111\/bjd.12816","article-title":"A truncating mutation in the laminin-332\u03b1 chain highlights the role of the LG45 proteolytic domain in regulating keratinocyte adhesion and migration","volume":"170","author":"Diociaiuti","year":"2014","journal-title":"Br. J. Dermatol."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1006\/excr.1997.3586","article-title":"Laminin-5 inhibits human keratinocyte migration","volume":"233","author":"Marinkovich","year":"1997","journal-title":"Exp. Cell Res."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1016\/S0002-9440(10)63762-5","article-title":"Keratinocytes from patients lacking collagen XVII display a migratory phenotype","volume":"164","author":"Tasanen","year":"2004","journal-title":"Am. J. Pathol."},{"key":"ref_146","doi-asserted-by":"crossref","unstructured":"L\u00f6ffek, S., Hurskainen, T., Jackow, J., Sigloch, F.C., Schilling, O., Tasanen, K., Bruckner-Tuderman, L., and Franzke, F.C. (2014). Transmembrane collagen XVII modulates integrin dependent keratinocyte migration via PI3K\/Rac1 signaling. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0087263"},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1002\/humu.21576","article-title":"Kindler syndrome: Extension of FERMT1 mutational spectrum and natural history","volume":"32","author":"Has","year":"2011","journal-title":"Hum. Mutat."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.anorl.2017.05.003","article-title":"Kindler syndrome complicated by invasive squamous cell carcinoma of the palate","volume":"135","author":"Souldi","year":"2018","journal-title":"Eur. Ann. Otorhinolaryngol. Head Neck Dis."},{"key":"ref_149","first-page":"338","article-title":"Natural history of Kindler syndrome and propensity for skin cancer - case report and literature review","volume":"16","author":"Saleva","year":"2018","journal-title":"J. Dtsch. Dermatol. Ges."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1186\/s13023-019-1158-6","article-title":"Assessment of the risk and characterization of non-melanoma skin cancer in Kindler syndrome: Study of a series of 91 patients","volume":"14","author":"Conti","year":"2019","journal-title":"Orphanet. J. Rare Dis."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.freeradbiomed.2017.05.013","article-title":"Kindlin-1 protects cells from oxidative damage through activation of ERK signalling","volume":"108","author":"Emmert","year":"2017","journal-title":"Free Radic. Biol. Med."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1111\/exd.14000","article-title":"Inhibition of cyclin-dependent kinase activity exacerbates H2 O2 -induced DNA damage in Kindler syndrome keratinocytes","volume":"28","author":"Emmert","year":"2019","journal-title":"Exp. Dermatol."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1111\/bjd.12184","article-title":"Induction of senescence pathways in Kindler syndrome primary keratinocytes","volume":"168","author":"Piccinni","year":"2013","journal-title":"Br. J. Dermatol."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.freeradbiomed.2014.07.046","article-title":"Nox family NADPH oxidases: Molecular mechanisms of activation","volume":"76","author":"Brandes","year":"2014","journal-title":"Free Radic. Biol. Med."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"4471","DOI":"10.1007\/s00018-017-2587-9","article-title":"Epithelial cell senescence: An adaptive response to pre-carcinogenic stresses?","volume":"74","author":"Abbadie","year":"2017","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.jid.2018.08.020","article-title":"Kindlin-1 regulates epidermal growth factor receptor signalling","volume":"139","author":"Michael","year":"2019","journal-title":"J. Investig. Dermatol."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"3355","DOI":"10.4049\/jimmunol.1302305","article-title":"The epidermal growth factor receptor is a regulator of epidermal complement component expression and complement activation","volume":"192","author":"Ananthoju","year":"2014","journal-title":"J. Immunol."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1038\/jid.2014.164","article-title":"Epithelial inflammation resulting from an inherited loss-of-function mutation in EGFR","volume":"134","author":"Campbell","year":"2014","journal-title":"J. Investig. Dermatol."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1002\/humu.21449","article-title":"Induction of phenotype modifying cytokines by FERMT1 mutations","volume":"32","author":"Heinemann","year":"2011","journal-title":"Hum. Mutat."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/nm.3490","article-title":"Kindlin-1 controls Wnt and TGF-\u03b2 availability to regulate cutaneous stem cell proliferation","volume":"20","author":"Rognoni","year":"2014","journal-title":"Nat. Med."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"S266","DOI":"10.1016\/j.jid.2019.07.303","article-title":"302 Molecular and mutational signatures of squamous cell carcinomas in epidermolysis bullosa","volume":"139","author":"Lu","year":"2019","journal-title":"J. Investig. Dermatol."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/20\/22\/5707\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:34:22Z","timestamp":1760189662000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/20\/22\/5707"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,14]]},"references-count":161,"journal-issue":{"issue":"22","published-online":{"date-parts":[[2019,11]]}},"alternative-id":["ijms20225707"],"URL":"https:\/\/doi.org\/10.3390\/ijms20225707","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,14]]}}}